Form 4: Zura Bio Ltd: Officer Michael Howell Acquires Shares in Private Placement

Officer Michael Howell reports the acquisition of Zura Bio Ltd shares through a private placement and indirect ownership via Mountaineer Biosciences, Inc.

Summary

• On April 22, 2024, Michael Howell, an officer of Zura Bio Ltd, acquired 7,987 Class A ordinary shares at $3.13 per share through a private placement.
• The transaction was made pursuant to a Securities Purchase Agreement dated April 18, 2024, between Zura Bio Ltd and Mountaineer Biosciences, Inc.
• Howell also indirectly owns 7,987 shares through Mountaineer Biosciences, Inc., where he serves as Co-Founder and has the power to vote and dispose of the shares.
• Howell directly owns 114,395 Class A ordinary shares.
• Howell disclaims beneficial ownership of the shares held by Mountaineer except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating an officer's stock purchase, which can be seen as a positive sign, but it doesn't provide enough information to strongly influence sentiment.

Positives

• An officer of the company is increasing their investment in the company, which can be seen as a positive signal.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholders as it signals confidence from a company officer.

Key Dates